|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/47 | (2006.01) |
| A61K 39/39558 | (2013.01) | ||
| A61K 39/39 | (2006.01) | ||
| A61K 45/06 | (2013.01) | ||
| A61K 9/20 | (2006.01) | ||
| A61K 9/2018 | (2013.01) | ||
| A61K 39/00 | (2006.01) | ||
| A61K 31/47 | (2013.01) | ||
| A61K 39/395 | (2006.01) | ||
| C07K 16/2827 | (2013.01) | ||
| A61K 45/06 | (2006.01) | ||
| A61K2039/545 | (2013.01) | ||
| A61P 35/00 | (2006.01) | ||
| C07K2317/76 | (2013.01) | ||
| A61P 35/04 | (2006.01) | ||
| A61P 35/00 | (2018.01) | ||
| C07K 16/28 | (2006.01) | ||
| A61P 35/04 | (2018.01) |
| (11) | Patento numeris | 3570840 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 18709192.1 |
| Europos patento paraiškos padavimo data | 2018-01-19 | |
| (97) | Europos patento paraiškos paskelbimo data | 2019-11-27 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2025-03-19 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2018/014523 |
| Data | 2018-01-19 |
| (87) | Numeris | WO 2018/136796 |
| Data | 2018-07-26 |
| (30) | Numeris | Data | Šalis |
| 201762448869 P | 2017-01-20 | US | |
| 201762458447 P | 2017-02-13 | US |
| (72) |
SCHWAB, Gisela , US
SCHEFFOLD, Christian , US
HESSEL, Colin , US
|
| (73) |
Exelixis, Inc. ,
1851 Harbor Bay Parkway, Alameda, CA 94502,
US
|
| (54) | COMBINATIONS OF CABOZANTINIB AND ATEZOLIZUMAB FOR THE TREATMENT OF CASTRATION-RESISTANT PROSTATE CANCER |
| COMBINATIONS OF CABOZANTINIB AND ATEZOLIZUMAB FOR THE TREATMENT OF CASTRATION-RESISTANT PROSTATE CANCER |